Rogasch, Julian M. M. http://orcid.org/0000-0002-0817-6532
Michaels, Liza
Baumgärtner, Georg L.
Frost, Nikolaj
Rückert, Jens-Carsten
Neudecker, Jens
Ochsenreither, Sebastian
Gerhold, Manuela
Schmidt, Bernd
Schneider, Paul
Amthauer, Holger
Furth, Christian
Penzkofer, Tobias
Funding for this research was provided by:
Charité - Universitätsmedizin Berlin
Article History
Received: 19 November 2022
Accepted: 8 February 2023
First Online: 23 February 2023
Declarations
:
: This is a retrospective, monocentric analysis. Approval was granted by the Ethics Committee of the Charité – Universitätsmedizin Berlin (25.05.2021, No EA2/100/21).
: Informed consent for data analysis for research purpose was obtained from all individual participants included in the study.
: The authors affirm that human research participants provided informed consent for the publication of the images in Fig. InternalRef removed as well as Figures InternalRef removed, InternalRef removed and InternalRef removed.
: Julian M.M. Rogasch is a participant in the BIH-Charité Digital Clinician Scientist Program funded by the Charité – Universitätsmedizin Berlin, the Berlin Institute of Health, and the German Research Foundation (DFG). Tobias Penzkofer was supported by Berlin Institute of Health (Clinician Scientist Grant, Platform Grant), Ministry of Education and Research (BMBF, 01KX2021, 68GX21001A), German Research Foundation (DFG, SFB 1340/2), Horizon 2020 (952172) and reports research agreements (no personal payments, outside of submitted work) with AGO, Aprea AB, ARCAGY-GINECO, Astellas Pharma Global Inc. (APGD), Astra Zeneca, Clovis Oncology, Inc., Dohme Corp, Holaira, Incyte Corporation, Karyopharm, Lion Biotechnologies, Inc., MedImmune, Merck Sharp, Millennium Pharmaceuticals, Inc., Morphotec Inc., NovoCure Ltd., PharmaMar S.A. and PharmaMar USA, Inc., Roche, Siemens Healthineers, and TESARO Inc., and fees for a book translation (Elsevier). All other authors have no relevant financial or non-financial interests to disclose.